Login to Your Account



Other news to note


Friday, January 10, 2014
Mallinkrodt Inc., of St. Louis, and Zogenix Inc., of San Diego, said they mutually agreed to end their co-promotion agreement covering Sumavel Dosepro (sumatriptan injection), a needle-free delivery of the migraine drug.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription